Cargando…

Safety of trastuzumab (Herceptin(®)) during pregnancy: two case reports

We report on two cases of women on trastuzumab therapy for breast cancer who became pregnant and delivered healthy live infants. At the time of reporting the children are growing and developing normally (ages 3 and 2).

Detalles Bibliográficos
Autores principales: Goodyer, Matthew J, Ismail, Jeffri RM, O'Reilly, Seamus P, Moylan, Eugene J, Ryan, C Anthony M, Hughes, Paul AF, O'Connor, Alan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2803989/
https://www.ncbi.nlm.nih.gov/pubmed/20062589
http://dx.doi.org/10.1186/1757-1626-2-9329
_version_ 1782176119489822720
author Goodyer, Matthew J
Ismail, Jeffri RM
O'Reilly, Seamus P
Moylan, Eugene J
Ryan, C Anthony M
Hughes, Paul AF
O'Connor, Alan
author_facet Goodyer, Matthew J
Ismail, Jeffri RM
O'Reilly, Seamus P
Moylan, Eugene J
Ryan, C Anthony M
Hughes, Paul AF
O'Connor, Alan
author_sort Goodyer, Matthew J
collection PubMed
description We report on two cases of women on trastuzumab therapy for breast cancer who became pregnant and delivered healthy live infants. At the time of reporting the children are growing and developing normally (ages 3 and 2).
format Text
id pubmed-2803989
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28039892010-01-10 Safety of trastuzumab (Herceptin(®)) during pregnancy: two case reports Goodyer, Matthew J Ismail, Jeffri RM O'Reilly, Seamus P Moylan, Eugene J Ryan, C Anthony M Hughes, Paul AF O'Connor, Alan Cases J Case Report We report on two cases of women on trastuzumab therapy for breast cancer who became pregnant and delivered healthy live infants. At the time of reporting the children are growing and developing normally (ages 3 and 2). BioMed Central 2009-12-16 /pmc/articles/PMC2803989/ /pubmed/20062589 http://dx.doi.org/10.1186/1757-1626-2-9329 Text en Copyright ©2009 Goodyer et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Goodyer, Matthew J
Ismail, Jeffri RM
O'Reilly, Seamus P
Moylan, Eugene J
Ryan, C Anthony M
Hughes, Paul AF
O'Connor, Alan
Safety of trastuzumab (Herceptin(®)) during pregnancy: two case reports
title Safety of trastuzumab (Herceptin(®)) during pregnancy: two case reports
title_full Safety of trastuzumab (Herceptin(®)) during pregnancy: two case reports
title_fullStr Safety of trastuzumab (Herceptin(®)) during pregnancy: two case reports
title_full_unstemmed Safety of trastuzumab (Herceptin(®)) during pregnancy: two case reports
title_short Safety of trastuzumab (Herceptin(®)) during pregnancy: two case reports
title_sort safety of trastuzumab (herceptin(®)) during pregnancy: two case reports
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2803989/
https://www.ncbi.nlm.nih.gov/pubmed/20062589
http://dx.doi.org/10.1186/1757-1626-2-9329
work_keys_str_mv AT goodyermatthewj safetyoftrastuzumabherceptinduringpregnancytwocasereports
AT ismailjeffrirm safetyoftrastuzumabherceptinduringpregnancytwocasereports
AT oreillyseamusp safetyoftrastuzumabherceptinduringpregnancytwocasereports
AT moylaneugenej safetyoftrastuzumabherceptinduringpregnancytwocasereports
AT ryancanthonym safetyoftrastuzumabherceptinduringpregnancytwocasereports
AT hughespaulaf safetyoftrastuzumabherceptinduringpregnancytwocasereports
AT oconnoralan safetyoftrastuzumabherceptinduringpregnancytwocasereports